Sugarbud Receives Dried Cannabis Sales License from Health Canada

 — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT, SUGR.WS, SUGR.DB) (“Sugarbud“) is pleased to announce it has received approval from Health Canada for its amended sales license (the “Sales License”) permitting the sale of dried cannabis products. Sugarbud is now able to directly sell its portfolio of exceptional craft cannabis products to all authorized provincialContinue reading “Sugarbud Receives Dried Cannabis Sales License from Health Canada”

Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial

– TheNewswire – August 10, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) advises that subsequent to Heath Canada issuing a No Objection Letter, they have requested specific protocol details regarding the Clinical Trial Application for CavaltinibTM, the target drug of the proposed joint venture with Biologic Pharmaceutical Research, before the trial may commence.Continue reading “Health Canada Requests Protocol Details of COVID-19 Phase 2 Clinical Trial”

Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial

– July 29, 2020 — Naturally Splendid Enterprises Ltd. (“Naturally Splendid” or “NSE”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce that the Company’s phase 2 clinical trial, as per its proposed joint venture with Biologic Pharmamedical Research for Cavaltinib(TM) (See Company news release, May 15, 2020.), has been approved for a COVID-19 clinical trial by Health Canada. The NoContinue reading “Health Canada Grants No Objection Letter to Proceed with COVID-19 Phase 2 Clinical Trial”

IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement

— IntelGenx Corp. (TSX V:IGX)(OTCQB:IGXT) (the “Company” or “IntelGenx”) today announced that it and Tilray, Inc. (“Tilray®”) have amended the exclusivity terms of their November 2018 license, development and supply agreement (the “Agreement”) to allow for IntelGenx’s co-development and commercialization of CBD products with additional partners. In consideration, IntelGenx shall pay a royalty to Tilray onContinue reading “IntelGenx and Tilray® Agree to Amend Certain Exclusivity Terms of Worldwide Cannabis-Infused VersaFilm® Agreement”

BevCanna Named Exclusive Canadian White Label Manufacturer of Marianna Naturals’ New CBD Wellness Beverage

Cannabis-infused beverage expert signs LOI with the popular U.S. health and beauty brand – Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE: BEV) (OTCQ: BVNNF) (FSE: 7BC) (“BevCanna” or the “Company”) announced today that it has entered into a non-binding letter of intent (the “LOI”) to manufacture white-label CBD wellness beverages for influential US health andContinue reading “BevCanna Named Exclusive Canadian White Label Manufacturer of Marianna Naturals’ New CBD Wellness Beverage”

Health Canada Requests Clinical Trial Protocol Details

– June 30, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”) (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to provide the following update in regards to the Clinical Trial Application (CTA) to Health Canada submitted May 17, 2020 as a treatment for Covid-19 with the target drug, Cavaltinib(TM). The Company continues to navigate the fast track CTA process withContinue reading “Health Canada Requests Clinical Trial Protocol Details”

VIVO CANNABIS™ Expands Cultivation and Processing Capacity

– VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) today announced its wholly-owned subsidiary, Canna Farms Limited (“Canna Farms“), has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. (“NCC“), has begun commercial production in its ethanol extraction suite. Facility Expansion Approval in Hope,Continue reading “VIVO CANNABIS™ Expands Cultivation and Processing Capacity”

Naturally Splendid Provides Clinical Trial Application Update

Naturally Splendid Enterprises Ltd.  (TSXV:NSP) (OTC:NSPDF) (Frankfurt:50N) provides the following update in regards to the Phase 2 Clinical Trial Application with Health Canada for a potential COVID-19 treatment. As an update to the Clinical Trial Application (CTA) process with Health Canada: A CTA was approved for submission to Health Canada on May 17, 2020. The HealthContinue reading “Naturally Splendid Provides Clinical Trial Application Update”

Auxly’s Joint Venture Partner, Sunens Farms, Receives Cultivation Licence at Large-Scale Facility

TORONTO, June 15, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company”), a consumer packaged goods company in the cannabis products market, is pleased to announce that its joint venture partner, Sunens Farms Inc. (“Sunens”), has secured a standard cultivation licence from Health Canada for the first phase of its fully automated,Continue reading “Auxly’s Joint Venture Partner, Sunens Farms, Receives Cultivation Licence at Large-Scale Facility”